# Title

 Food and Drugs. PART 878â€”GENERAL AND PLASTIC SURGERY DEVICES


# ID

 CFR-2018-title21-vol8.Pt. 878


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['least', 'before', 'within', 'prior to', 'greater than', 'maximum', 'less than', 'after', 'minimum of', 'at least']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Duration    | ['18.0 year']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Condition   | ['until', 'unless', 'where', 'subject to', 'when', 'if']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Entities    | ['Hydrophilic', 'Speculum', 'Material', 'Chin', 'Silicone', 'Organ', 'United States Pharmacopeia', 'Industry', 'Eye', 'Internal', 'Pneumatic', 'Laser', 'Surgeon', 'Chemical', 'Esophageal', 'Cryosurgical', 'Electrosurgical', 'Sunlamp', 'Poly', 'Nose', 'Absorbable', 'Tissue', 'Ear', 'Skin', 'Scope', 'External', 'Food', 'Plastic', 'Implantable', 'Natural', 'Low', 'Nonresorbable', 'Industry and FDA', 'Ultraviolet', 'Performance', 'Extracorporeal', 'Suture', 'Manual', 'Drape', 'Powered', 'Single', 'Topical', 'Monograph', 'Guidance', 'Tracheal', 'Noninflatable', 'Removable', 'Appropriate', 'Nonpowered', 'Nonabsorbable', 'Suction', 'Magnetic', 'Nonpneumatic', 'Hydrogel'] |
| Date        | ['2002-01-02', '2018-06-01', '1991-07-09', '1999-11-17', '1976-05-28']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                      |
|:--------------|:-----------------------------------------------------------------------------------------------------------------------------|
| after         | III (premarket approval) shall not be commercially distributed after the date shown in the regulation classifying the        |
| before        | Before FDA requires that a device commercially distributed before the enactment date of the amendments, or a                 |
| before        | Before FDA requires that a device commercially distributed before the enactment date of the amendments, or a                 |
| after         | the grace period ending on the 90th day after its promulgation or on the last day of                                         |
| after         | the grace period ending on the 90th day after its promulgation or on the last day of                                         |
| after         | equivalent, device introduced into commercial distribution on or after May 28, 1976, including a device formerly marketed    |
| before        | or declaring completed a PDP for the device before the device is commercially distributed unless it is                       |
| before        | an approval under section 515 of the act before  commercial distribution.                                                    |
| before        | an approval under section 515 of the act before  being commercially distributed.                                             |
| before        | an approval under section 515 of the act before  commercial distribution.                                                    |
| within        | or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of    |
| before        | must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate commerce |
| before        | to the desired size with sterile isotonic saline before  or after implantation.                                              |
| after         | desired size with sterile isotonic saline before or after  implantation.                                                     |
| before        | with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast                     |
| before        | with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast                     |
| before        | with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast                     |
| before        | with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast                     |
| before        | PMA or a declared completed PDP in effect before  being placed in commercial distribution.                                   |
| before        | to the desired size with sterile isotonic saline before  or after implantation.                                              |
| after         | desired size with sterile isotonic saline before or after  implantation.                                                     |
| within        | layer and an outer covering of polyurethane; contained within the inner shell is a fixed amount of                           |
| before        | with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast                           |
| before        | with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast                           |
| before        | with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast                           |
| before        | with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast                           |
| before        | prosthesis shall have an approved PMA in effect before  being placed in commercial distribution.                             |
| before        | instruments and materials used to make maxillofacial impressions before  molding an external prosthesis.                     |
| before        | under section 515 of the act is required before  this device may be commercially distributed.                                |
| least         | or other material in combination with water (at least  50 percent) and capable of absorbing exudate.                         |
| maximum       | device's ranges of operation, including flow rates and maximum suction pressures; (v) Demonstrate the ability of the         |
| maximum       | and (vi) Maximum flow rate and suction pressure. maximum                                                                     |
| within        | device using radiofrequency energy to produce localized heating within  tissues for non-invasive aesthetic use.              |
| less than     | device is woven from material made of not less than 50 percent by mass cotton, cellulose, or a                               |
| maximum       | all visible device components by irrigation; (ii) The maximum amount of time the device may be left                          |
| within        | amount of time the device may be left within the body; (iii) A shelf life; (iv) A                                            |
| before        | to be used to lubricate the user's hand before  putting on a surgeon's glove.                                                |
| before        | under section 515 of the act is required before  this device may be commercially distributed.                                |
| before        | under section 515 of the act is required before  this device may be commercially distributed.                                |
| within        | using focused ultrasound to produce localized, mechanical motion within tissues and cells for the purpose of producing       |
| before        | who will be exposed to UV radiation immediately before  the use of the product.                                              |
| at least      | approaches the equipment and the text shall be at least  10 millimeters (height).                                            |
| prior to      | prescription use device that is intended for use prior to or during general surgical procedures to demarcate selected        |
| prior to      | must not be used on a non-sterile surface prior to  use internally.                                                          |
| minimum of    | powered suction pump has a motor with a minimum of 1/3 horsepower, a variable vacuum range from 0                            |
| within        | laser energy for the disruption of adipocyte cells within the fat layer for the release of fat                               |
| greater than  | apply humidified oxygen topically at a pressure slightly greater than atmospheric pressure to aid healing of chronic skin    |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 18.0 year  | Manufacturers of sunlamp products and UV lamps intended for use in sunlamp products shall provide or cause to be provided in the user instructions, as well as all consumer-directed catalogs, specification sheets, descriptive brochures, and Web pages in which sunlamp products or UV lamps intended for use in sunlamp products are offered for sale, the following contraindication and warning statements: |
|            |               (A) &#8220;Contraindication: This product is contraindicated for use on persons under the age of 18 years.&#8221;                                                                                                                                                                                                                                                                                   |
|            |               (B) &#8220;Contraindication: This product must not be used if skin lesions or open wounds are present.&#8221;                                                                                                                                                                                                                                                                                       |
|            |               (C) &#8220;Warning: This product should not be used on individuals who have had skin cancer or have a family history of skin cancer.&#8221;                                                                                                                                                                                                                                                         |
|            |               (D) &#8220;Warning: Persons repeatedly exposed to UV radiation should be regularly evaluated for skin cancer.&#8221;                                                                                                                                                                                                                                                                                |
|            |               (c) Performance standard.                                                                                                                                                                                                                                                                                                                                                                           |


## Condition

| Condition   | Context                                                                                                                             |
|:------------|:------------------------------------------------------------------------------------------------------------------------------------|
| subject to  | of every device that is, or will be, subject to  the regulation.                                                                    |
| unless      | Regulations are to chapter I of title 21 unless  otherwise noted.                                                                   |
| unless      | date shown in the regulation classifying the device unless the manufacturer has an approval under section 515                       |
| unless      | Accordingly,  unless an effective date of the requirement for premarket                                                             |
| unless      | the device before the device is commercially distributed unless  it is reclassified.                                                |
| subject to  | is classified into class III and that is subject to the transitional provisions of section 520(l) of the                            |
| where       | or the device is intended for lay use where the former intended use was by health care                                              |
| when        | other than immunoglobulin G (IgG) or IgG assays when the results are not qualitative, or are used                                   |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| where       | be implanted to reinforce soft tissue or bone where  weakness exists.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | in part 807, subpart E of this chapter subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | in part 807, subpart E of this chapter subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | in part 807, subpart E of this chapter subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | in part 807, subpart E of this chapter subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;878.9.                                            |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| until       | not amenable to tourniquet use, to control bleeding until  surgical care is acquired.                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| if          | drug in the treatment of a dermatologic disorder if the labeling of the drug intended for use                                       |
| when        | be permanently affixed or inscribed on the product when fully assembled for use so as to be                                         |
| when        | (or tanning booth door) is open or closed when the person who will be exposed approaches the                                        |
| if          | instructions, as well as all consumer-directed catalogs, spec if ication sheets, descriptive brochures, and Web pages in            |
| subject to  | lamps intended for use in sunlamp products are subject to the electronic product performance standard at &#167;&#8201;1040.20 of    |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| until       | fill the biopsy void and remains in place until  resorbed.                                                                          |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | The devices  subject to this paragraph (b)(2) are exempt from the premarket                                                         |
| subject to  | The devices  subject to this paragraph (b)(2) are exempt from the premarket                                                         |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| where       | in soft tissue approximation, including pediatric cardiovascular tissue where  growth is expected to occur, and ophthalmic surgery. |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;878.9.                                                               |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |
| subject to  | subpart E of part 807 of this chapter, subject to  the limitations in &#167;&#8201;878.9.                                           |


## Entities

| Entities                   | Context                                                                                                                                                   |
|:---------------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food                       | Food  and Drugs.                                                                                                                                          |
| Scope                      | Scope .                                                                                                                                                   |
| Speculum                   | Speculum  and accessories.                                                                                                                                |
| Silicone                   | Silicone  inflatable breast prosthesis.                                                                                                                   |
| Chin                       | Chin  prosthesis.                                                                                                                                         |
| Ear                        | Ear  prosthesis.                                                                                                                                          |
| Esophageal                 | Esophageal  prosthesis.                                                                                                                                   |
| Guidance                   | special control for this device is FDA's &#8220; Guidance for the Content of Premarket Notification Submissions for                                       |
| Nose                       | Premarket Notification Submissions for Esophageal and Tracheal Prostheses.&#8221; Nose  prosthesis.                                                       |
| Tracheal                   | Tracheal  prosthesis.                                                                                                                                     |
| Guidance                   | special control for this device is FDA's &#8220; Guidance for the Content of Premarket Notification Submissions for                                       |
| External                   | External  aesthetic restoration prosthesis.                                                                                                               |
| Noninflatable              | Noninflatable  extremity splint.                                                                                                                          |
| Plastic                    | Plastic  surgery kit and accessories.                                                                                                                     |
| Tissue                     | Tissue  adhesive.                                                                                                                                         |
| Tissue                     | Tissue adhesives for the topical approximation of skin may                                                                                                |
| Tissue                     | Tissue adhesive with adjunct wound closure device for topical                                                                                             |
| Guidance                   | special control for this device is FDA's &#8220; Guidance for Industry and FDA Staff; Class II Special                                                    |
| Industry                   | control for this device is FDA's &#8220;Guidance for Industry and FDA Staff; Class II Special Controls Guidance                                           |
| Nonresorbable              | Nonresorbable  gauze/sponge for external use.                                                                                                             |
| Poly                       | II Special Controls Guidance Document: Wound Dressing With Poly (Diallyl Dimethyl Ammonium Chloride) (pDADMAC) Additive.&#8221; See &#167;&#8201;878.1(e) |
| Hydrophilic                | Hydrophilic  wound dressing.                                                                                                                              |
| Hydrogel                   | Hydrogel  wound dressing and burn dressing.                                                                                                               |
| Silicone                   | Silicone sheeting is intended for use in the management                                                                                                   |
| Organ                      | Organ  bag.                                                                                                                                               |
| Implantable                | Implantable  clip.                                                                                                                                        |
| Removable                  | Removable  skin clip.                                                                                                                                     |
| Guidance                   | special controls for this device is FDA's &#8220; Guidance for Industry and FDA Staff; Class II Special                                                   |
| Industry                   | controls for this device is FDA's &#8220;Guidance for Industry and FDA Staff; Class II Special Controls Guidance                                          |
| Cryosurgical               | Cryosurgical  unit and accessories.                                                                                                                       |
| Performance                | Performance testing must: (i) Characterize the tear resistance, tensile                                                                                   |
| Drape                      | Drape  adhesive.                                                                                                                                          |
| Electrosurgical            | Electrosurgical  cutting and coagulation device and accessories.                                                                                          |
| Low                        | Low  energy ultrasound wound cleaner.                                                                                                                     |
| Electrosurgical            | Electrosurgical  device for over-the-counter aesthetic use.                                                                                               |
| Eye                        | Eye  pad.                                                                                                                                                 |
| Nonabsorbable              | Nonabsorbable  gauze for internal use.                                                                                                                    |
| Nonabsorbable              | Nonabsorbable gauze for internal use is a device made                                                                                                     |
| Appropriate                | Appropriate analysis/testing must demonstrate that the product: Controls bleeding,                                                                        |
| Chemical                   | characterization, including swelling percent and particulate size; (iv) Chemical characterization; (v) Radiopacity testing; and (vi) Mechanical integrity |
| Surgeon                    | Surgeon 's gloving cream.                                                                                                                                 |
| Surgeon                    | Surgeon 's gloving cream is an ointment intended to                                                                                                       |
| Absorbable                 | Absorbable  poly(glycolide/l-lactide) surgical suture.                                                                                                    |
| United States Pharmacopeia | A PGL suture meets  United States Pharmacopeia  (U.S.P.)                                                                                                  |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Absorbable                 | Absorbable  poly(hydroxybutyrate) surgical suture produced by recombinant DNA technology.                                                                 |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Ultraviolet                | Ultraviolet  lamp for dermatologic disorders.                                                                                                             |
| Sunlamp                    | Sunlamp products and ultraviolet lamps intended for use in                                                                                                |
| Sunlamp                    | Sunlamp products and UV lamps intended for use in                                                                                                         |
| Skin                       | Skin  marker.                                                                                                                                             |
| Internal                   | Internal  tissue marker.                                                                                                                                  |
| Material                   | Material  names and specific designation numbers must be provided.                                                                                        |
| Single                     | (iii)  Single use only labeling must be labeled directly on                                                                                               |
| Nonpowered                 | Nonpowered , single patient, portable suction apparatus.                                                                                                  |
| Extracorporeal             | Extracorporeal  shock wave device for treatment of chronic wounds.                                                                                        |
| Implantable                | Implantable  staple.                                                                                                                                      |
| Absorbable                 | Absorbable  lung biopsy plug.                                                                                                                             |
| Removable                  | Removable  skin staple.                                                                                                                                   |
| Powered                    | Powered surgical instrument for improvement in the appearance of                                                                                          |
| Laser                      | Laser surgical instrument for use in general and plastic                                                                                                  |
| Magnetic                   | Magnetic  surgical instrument system.                                                                                                                     |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Absorbable                 | Absorbable  polydioxanone surgical suture.                                                                                                                |
| Guidance                   | the device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                                |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Suture                     | Suture  retention device.                                                                                                                                 |
| Manual                     | Manual operating table and accessories and manual operating chair                                                                                         |
| Nonabsorbable              | Nonabsorbable  poly(ethylene terephthalate) surgical suture.                                                                                              |
| Nonabsorbable              | Nonabsorbable poly(ethylene terephthalate) surgical suture is a multifilament, nonabsorbable,                                                             |
| Monograph                  | Monograph for Nonabsorbable Surgical Sutures; it may be provided                                                                                          |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Nonabsorbable              | Nonabsorbable  polypropylene surgical suture.                                                                                                             |
| Nonabsorbable              | Nonabsorbable polypropylene surgical suture is a monofilament, nonabsorbable, sterile,                                                                    |
| United States Pharmacopeia | The polypropylene surgical suture meets  United States Pharmacopeia  (U.S.P.)                                                                             |
| Monograph                  | Monograph for Nonabsorbable Surgical Sutures; it may be undyed                                                                                            |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| United States Pharmacopeia | The polyamide surgical suture meets  United States Pharmacopeia  (U.S.P.)                                                                                 |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Natural                    | Natural  nonabsorbable silk surgical suture.                                                                                                              |
| Natural                    | Natural nonabsorbable silk surgical suture is a nonabsorbable, sterile,                                                                                   |
| Natural                    | Natural nonabsorbable silk surgical suture is indicated for use                                                                                           |
| Natural                    | Natural nonabsorbable silk surgical suture meets the United States                                                                                        |
| United States Pharmacopeia | Natural nonabsorbable silk surgical suture meets the  United States Pharmacopeia  (U.S.P.)                                                                |
| Natural                    | Natural nonabsorbable silk surgical suture may be braided or                                                                                              |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Guidance                   | this device is FDA's &#8220;Class II Special Controls Guidance  Document: Surgical Sutures;                                                               |
| Industry and FDA           | Special Controls Guidance Document: Surgical Sutures; Guidance for Industry and FDA .&#8221; See &#167;&#8201;878.1(e) for the availability of this       |
| Suction                    | Suction  lipoplasty system.                                                                                                                               |
| Chemical                   | reaction must be mitigated through the following: (i) Chemical characterization and toxicological risk assessment of the treated                          |
| Low                        | Low  level laser system for aesthetic use (a) Identification.                                                                                             |
| Guidance                   | device is the FDA guidance document entitled &#8220; Guidance for Industry and Food and Drug Administration Staff;                                        |
| Industry                   | is the FDA guidance document entitled &#8220;Guidance for Industry and Food and Drug Administration Staff; Class II                                       |
| Topical                    | Topical  oxygen chamber for extremities.                                                                                                                  |
| Nonpneumatic               | Nonpneumatic  tourniquet.                                                                                                                                 |
| Pneumatic                  | Pneumatic  tourniquet.                                                                                                                                    |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1976-05-28 | (b) Any new, not substantially equivalent, device introduced into commercial distribution on or after May 28, 1976, including a device formerly marketed that has been substantially altered, is classified by statute (section 513(f) of the act) into class III without any grace period and FDA must have issued an order approving a PMA or declaring completed a PDP for the device before the device is commercially distributed unless it is reclassified. |
| 1976-05-28 | Accordingly, the regulation for such a class III device states that as of the enactment date of the amendments, May 28, 1976, the device must have an approval under section 515 of the act before commercial distribution.                                                                                                                                                                                                                                       |
| 1976-05-28 | Accordingly, the regulation for such a class III transitional device states that as of the enactment date of the amendments, May 28, 1976, the device must have an approval under section 515 of the act before commercial distribution.                                                                                                                                                                                                                          |
| 1999-11-17 | A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976, or that has, on or before November 17, 1999, been found to be substantially equivalent to a silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976.                          |
| 1976-05-28 | A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976, or that has, on or before November 17, 1999, been found to be substantially equivalent to a silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976.                          |
| 1999-11-17 | A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976, or that has, on or before November 17, 1999, been found to be substantially equivalent to a silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976.                          |
| 1976-05-28 | A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before November 17, 1999, for any silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976, or that has, on or before November 17, 1999, been found to be substantially equivalent to a silicone inflatable breast prosthesis that was in commercial distribution before May 28, 1976.                          |
| 1991-07-09 | A PMA is required to be filed with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976, or that has on or before July 9, 1991 been found to be substantially equivalent to a silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976.                                                                          |
| 1976-05-28 | A PMA is required to be filed with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976, or that has on or before July 9, 1991 been found to be substantially equivalent to a silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976.                                                                          |
| 1991-07-09 | A PMA is required to be filed with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976, or that has on or before July 9, 1991 been found to be substantially equivalent to a silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976.                                                                          |
| 1976-05-28 | A PMA is required to be filed with the Food and Drug Administration on or before July 9, 1991 for any silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976, or that has on or before July 9, 1991 been found to be substantially equivalent to a silicone gel-filled breast prosthesis that was in commercial distribution before May 28, 1976.                                                                          |
| 1976-05-28 | As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed.                                                                                                                                                                                                                                                                                                                                      |
| 2018-06-01 | A nonabsorbable expandable hemostatic sponge for temporary internal use is a prescription device intended to be placed temporarily into junctional, non-compressible wounds, which are not amenable to tourniquet use, to control bleeding until surgical care is acquired.                                                                                                                                                                                       |
| 1976-05-28 | As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed.                                                                                                                                                                                                                                                                                                                                      |
| 1976-05-28 | As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed.                                                                                                                                                                                                                                                                                                                                      |
| 2002-01-02 | A surgical skin degreaser or an adhesive tape solvent is a device that consists of a liquid such as 1,1,2-trichloro-1,2,2-trifluoroethane; 1,1,1-trichloroethane; and 1,1,1-trichloroethane with mineral spirits intended to be used to dissolve surface skin oil or adhesive tape.                                                                                                                                                                               |


